Articles by Maureen T. Kelly (8)

ABT-335 in Combination with Rosuvastatin Improves Multiple Lipid Ratios in Patients with Mixed Dyslipidemia

Michael H. Davidson, Dawn M. Carlson, Robert M. Guthrie, Maureen T. Kelly, Aditya Lele, Carolyn M. Setze and Darryl J. Sleep

Journal of Clinical Lipidology 2 ( 3 ): 211 - 212 , 2008

Efficacy and Safety of ABT-335 (Fenofibric Acid) in Combination with Rosuvastatin in Patients with Mixed Dyslipidemia: A Phase 3 Study

Peter H. Jones, Susan M. Buttler, Michael H. Davidson, Moti L. Kashyap, Maureen T. Kelly, Carolyn M. Setze, Darryl J. Sleep and James C. Stolzenbach

Journal of Clinical Lipidology 2 ( 3 ): 218 - 219 , 2008

Effects of ABT-335 in Combination with Rosuvastatin on Low-Density Lipoprotein Particle Size in Patients with Mixed Dyslipidemia

Peter H. Jones, Dawn M. Carlson, Thomas Dayspring, Maureen T. Kelly, Aditya Lele, Carolyn M. Setze and Darryl J. Sleep

Journal of Clinical Lipidology 2 ( 3 ): 219 - 220 , 2008

Long-term safety and efficacy of fenofibric acid in combination with statin therapy for the treatment of patients with mixed dyslipidemia

Harold E. Bays, Peter H. Jones, Syed M. Mohiuddin, Maureen T. Kelly, Hsiaoming Sun, Carolyn M. Setze, Susan M. Buttler, Darryl J. Sleep and James C. Stolzenbach

Journal of Clinical Lipidology 2 ( 6 ): 426 - 435 , 2008

Efficacy and safety of fenofibric acid in combination with a statin in patients with mixed dyslipidemia: Pooled analysis of three phase 3, 12-week randomized, controlled studies

Peter H. Jones, Michael H. Davidson, Anne C. Goldberg, Carl J. Pepine, Maureen T. Kelly, Susan M. Buttler, Carolyn M. Setze, Aditya Lele, Darryl J. Sleep and James C. Stolzenbach

Journal of Clinical Lipidology 3 ( 2 ): 125 - 137 , 2009

Effects of combination therapy with rosuvastatin and fenofibric acid in patients with mixed dyslipidemia and high-sensitivity C-reactive protein (≥2 mg/L)

Christie M. Ballantyne, Michael H. Davidson, Carolyn M. Setze and Maureen T. Kelly

Journal of Clinical Lipidology 5 ( 5 ): 401 - 407 , 2011

Efficacy and Safety of Fenofibric Acid + Rosuvastatin Versus Rosuvastatin Alone in Patients With Mixed Dyslipidemia and Stage 3 Chronic Kidney Disease

Debra L. Weinstein, Laura A. Williams, Dawn M. Carlson, Maureen T. Kelly, James W. Blasetto, Kim M. Burns, Carolyn M. Setze, Aditya Lele and James C. Stolzenbach

Journal of Clinical Lipidology 6 ( 3 ): 269 - 270 , 2012

Attainment of goal/desirable lipid levels in patients with mixed dyslipidemia after 12 weeks of treatment with fenofibric acid and rosuvastatin combination therapy: A pooled analysis of controlled studies

Eli M. Roth, Robert S. Rosenson, Peter H. Jones, Michael H. Davidson, Maureen T. Kelly, Carolyn M. Setze, Aditya Lele and Kamlesh Thakker

Journal of Clinical Lipidology 6 ( 6 ): 534 - 544 , 2012